Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Simultaneous two-level intradural disc herniation mimicking intradural tumors: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Appraising spina bifida care in Africa: Challenges, implications, and progress - A perspective review.

Journal of public health research·2026
Same author

AI in UK Medical Education: A Framework for Curriculum Reform.

JMIR medical education·2026
Same author

Leveraging single-cell and spatial omics for brain tumour insights to improve therapeutic strategies.

Molecular brain·2026
Same author

Organoids as next-generation models for investigating intracranial tumours.

Molecular brain·2026
Same author

Immune cell imaging in the glioma microenvironment.

Brain research·2026

相关实验视频

Updated: May 29, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

使用人工智能预测恶性质瘤的存活率.

Wireko Andrew Awuah1, Adam Ben-Jaafar2, Subham Roy3

  • 1Department of Research, Toufik's World Medical Association, Sumy, Ukraine. andyvans36@yahoo.com.

European journal of medical research
|January 31, 2025
PubMed
概括

人工智能 (AI) 模型显著改善了恶性质瘤患者的生存预测. 结合成像和临床数据的综合人工智能方法为准确的预后和个性化治疗提供了最大的潜力.

关键词:
人工智能 (AI) 是一种人工智能.深度学习 (DL) 是指深度学习.机器学习 (ML) 是指机器学习.恶性质质瘤是一种恶性质瘤.生存预测方法的方法.

更多相关视频

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.8K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.3K

相关实验视频

Last Updated: May 29, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.8K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.3K

科学领域:

  • 神经瘤学神经瘤学
  • 医学成像医学成像
  • 人工智能的人工智能是人工智能.

背景情况:

  • 恶性质瘤,如质母细胞瘤,是具有不良预后的侵袭性脑瘤.
  • 传统的生存预测方法 (Kaplan-Meier,Cox Proportional Hazards) 在准确性方面存在局限性.
  • 准确的生存预测对于质瘤管理和研究至关重要,利用整体生存率 (OS) 和无进展生存率 (PFS).

研究的目的:

  • 为了比较基于成像,非成像和综合人工智能模型对质瘤存活率预测的有效性.
  • 突出人工智能,机器学习 (ML) 和深度学习 (DL) 的进展,以整合多式联网数据.
  • 为应对挑战,并提出解决方案,用于AI实施在质瘤预后.

主要方法:

  • 从成像数据中利用放射学来识别瘤特征.
  • 为非成像AI模型利用临床和分子生物标记数据.
  • 开发结合人工智能模型,整合多模式数据源 (成像,临床,分子).

主要成果:

  • 基于成像的AI模型通过放射学证明了高预测准确度.
  • 非成像人工智能模型使用临床和遗传数据提供了互补的见解.
  • 结合人工智能模型,集成多种数据模式,显示出准确生存预测的最大潜力.

结论:

  • 人工智能,特别是结合方法,在质瘤生存预测方面提供了显著的改进.
  • 先进的AI技术可以实现个性化的治疗策略,并提高预后准确性.
  • 解决数据异质性和可解释性等局限性是人工智能在质瘤管理中广泛采用的关键.